Αβ-Crystallin and Laminin-332 Are Prognostic Markers for Triple Negative Breast Cancers in a Brazilian Series

International Journal of Cancer and Clinical Research
doi 10.23937/2378-3419/1410103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ClinMed International Library

Related search

Molecular Stratification of Triple-Negative Breast Cancers

Oncologist
Cancer ResearchMedicineOncology
2010English

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?

Journal of Oncology
Oncology
2020English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Transgelin: A Potentially Useful Diagnostic Marker Differentially Expressed in Triple-Negative and Non–triple-Negative Breast Cancers

Human Pathology
Forensic MedicinePathology
2015English

ECT2 Associated to PRICKLE1 Are Poor-Prognosis Markers in Triple-Negative Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

BRCA1/2-negative Hereditary Triple-Negative Breast Cancers Exhibit BRCAness

International Journal of Cancer
Cancer ResearchOncology
2017English

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy